This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Gibbon JH. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954;37:171–85. PMID: 13154149GibbonJHApplication of a mechanical heart and lung apparatus to cardiac surgery19543717185PMID: 13154149Search in Google Scholar
Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery. Anesthesiology 2002;97:215–52. doi: 10.1097/00000542-200207000-00030LaffeyJGBoylanJFChengDCThe systemic inflammatory response to cardiac surgery2002972155210.1097/00000542-200207000-00030Open DOISearch in Google Scholar
Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997;112:676–92. doi: 10.1378/ chest.112.3.676WanSLeClercJLVincentJLInflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies19971126769210.1378/ chest.112.3.676Open DOISearch in Google Scholar
Milei J, Forcada P, Fraga CG, Grana DR, Iannelli G, Chiariello M, Tritto I, Ambrosio G. Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion. Cardiovasc Res 2007;73:710–9. doi: 10.1016/j.cardiores.2006.12.007MileiJForcadaPFragaCGGranaDRIannelliGChiarielloMTrittoIAmbrosioGRelationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion200773710910.1016/j.cardiores.2006.12.007Open DOISearch in Google Scholar
Leong JY, van der Merwe J, Pepe S, Bailey M, Perkins A, Lymbury R, Esmore D, Marasco S, Rosenfeldt F. Perioperative metabolic therapy improves redox status and outcomes in cardiac surgery patients: a randomized trial. Heart Lung Circ 2010;19:584–91. doi: 10.1016/j. hlc.2010.06.65LeongJYvander Merwe JPepeSBaileyMPerkinsALymburyREsmoreDMarascoSRosenfeldtFPerioperative metabolic therapy improves redox status and outcomes in cardiac surgery patients: a randomized trial2010195849110.1016/j. hlc.2010.06.65Open DOISearch in Google Scholar
Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992;339:1523–6. doi: 10.1016/0140-6736(92)91277-fRenaudSdeLorgeril MWine, alcohol, platelets, and the French paradox for coronary heart disease19923391523610.1016/0140-6736(92)91277-fOpen DOISearch in Google Scholar
Siemann EH, Creasy LL. Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic 1992;43:49–52.SiemannEHCreasyLLConcentration of the phytoalexin resveratrol in wine1992434952Search in Google Scholar
Chen H, Tuck T, Ji X, Zhou X, Kelly G, Cuerrier A, Zhang J. Quality assessment of Japanese knotweed (Fallopia japonica) grown on Prince Edward Island as a source of resveratrol. J Agric Food Chem 2013;61:6383–92. doi: 10.1021/jf4019239ChenHTuckTJiXZhouXKellyGCuerrierAZhangJQuality assessment of Japanese knotweed (Fallopia japonica) grown on Prince Edward Island as a source of resveratrol20136163839210.1021/jf4019239Open DOISearch in Google Scholar
Cottart CH, Nivet-Antoine V, Laguillier-Morizot C, Beaudeux JL. Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res 2010;54:7–16. doi: 10.1002/mnfr.200900437CottartCHNivet-AntoineVLaguillier-MorizotCBeaudeuxJLResveratrol bioavailability and toxicity in humans20105471610.1002/mnfr.200900437Open DOISearch in Google Scholar
Walle T, Hsieh F, DeLegge MH, Oatis JEJr, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabol Disposit 2004;32:1377–82.WalleTHsiehFDeLeggeMHOatisJEJrWalleUKHigh absorption but very low bioavailability of oral resveratrol in humans200432137782Search in Google Scholar
Juan ME, Vinardell MP, Planas JM. The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J Nutr 2002;132:257–60. doi: 10.1093/jn/132.2.257JuanMEVinardellMPPlanasJMThe daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful20021322576010.1093/jn/132.2.257Open DOISearch in Google Scholar
Dirks Naylor AJ. Celular effects of resveratrol in skeletal muscle. Life Sci 2009;84:637–40. doi: 10.1016/j.lfs.2009.02.011DirksNaylor AJCelular effects of resveratrol in skeletal muscle2009846374010.1016/j.lfs.2009.02.011Open DOISearch in Google Scholar
Bradamante S, Barenghi L, Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 2004;22:169–88. doi: 10.1111/ j.1527-3466.2004.tb00139.xBradamanteSBarenghiLVillaACardiovascular protective effects of resveratrol2004221698810.1111/ j.1527-3466.2004.tb00139.xOpen DOISearch in Google Scholar
Hao HD, He LR. Mechanisms of cardiovascular protection by resveratrol. J Med Food 2004;7:290–8. doi: 10.1089/jmf.2004.7.290HaoHDHeLRMechanisms of cardiovascular protection by resveratrol20047290810.1089/jmf.2004.7.290Open DOISearch in Google Scholar
Wang Z, Zou J, Huang Y, Cao K, Xu Y, Wu JM. Effect of resveratrol on platelet aggregation in vivo and in vitro. Chin Med J (Engl) 2002;115:378–80. PMID: 11940369WangZZouJHuangYCaoKXuYWuJMEffect of resveratrol on platelet aggregation in vivo and in vitro200211537880PMID: 11940369Search in Google Scholar
Chu LM, Lassaletta AD, Robich MP, Sellke FW. Resveratrol in the prevention and treatment of coronary artery disease. Curr Atheroscler Rep 2011;13:439–46. doi: 10.1007/s11883-011-0202-3ChuLMLassalettaADRobichMPSellkeFWResveratrol in the prevention and treatment of coronary artery disease2011134394610.1007/s11883-011-0202-3Open DOISearch in Google Scholar
Plauth A, Geikowski A, Cichon S, Wowro SJ, Liedgens L, Rousseau M, Weidner C, Fuhr L, Kliem M, Jenkins G, Lotito S, Wainwright LJ, Sauer S. Hormetic shifting of redox environment by pro-oxidative resveratrol protects cells against stress. Free Radic Biol Med 2016;99:608–22. doi: 10.1016/j.freeradbiomed.2016.08.006PlauthAGeikowskiACichonSWowroSJLiedgensLRousseauMWeidnerCFuhrLKliemMJenkinsGLotitoSWainwrightLJSauerSHormetic shifting of redox environment by pro-oxidative resveratrol protects cells against stress2016996082210.1016/j.freeradbiomed.2016.08.006Open DOISearch in Google Scholar
Xu H-C, Lv W, Wang L-M, Ye P, Hu J. Early protection by resveratrol in rat lung transplantation. Med Sci Monit 2019;25:760–70. doi: 10.12659/MSM.912345XuH-CLvWWangL-MYePHuJEarly protection by resveratrol in rat lung transplantation2019257607010.12659/MSM.912345Open DOISearch in Google Scholar
Cheng L, Jin Z, Zhao R, Ren K, Deng C, Yu S. Resveratrol attenuates inflammation and oxidative stress induced by myocardial ischemia-reperfusion injury: role of Nrf2/ARE pathway. Int J Clin Exp Med 2015;8:10420–8. PMCID: PMC4565215ChengLJinZZhaoRRenKDengCYuSResveratrol attenuates inflammation and oxidative stress induced by myocardial ischemia-reperfusion injury: role of Nrf2/ARE pathway20158104208PMCID: PMC4565215Search in Google Scholar
Penumathsa SV, Maulik N. Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease. Can J Physiol Pharmacol 2009;87:275–86. doi: 10.1139/Y09-013PenumathsaSVMaulikNResveratrol: a promising agent in promoting cardioprotection against coronary heart disease2009872758610.1139/Y09-013Open DOISearch in Google Scholar
Wang XL, Li T, Li JH, Miao SY, Xiao XZ. The effects of resveratrol on inflammation and oxidative stress in a rat model of chronic obstructive pulmonary disease. Molecules 2017;22(9):1529. doi: 10.3390/molecules22091529WangXLLiTLiJHMiaoSYXiaoXZThe effects of resveratrol on inflammation and oxidative stress in a rat model of chronic obstructive pulmonary disease2017229152910.3390/molecules22091529Open DOISearch in Google Scholar
Usta E, Mustafi M, Walker T, Ziemer G. Resveratrol suppresses apoptosis in intact human cardiac tissue - in vitro model simulating extracorporeal circulation. J Cardiovasc Surg 2011;52:399–409. PMID: 21577194UstaEMustafiMWalkerTZiemerGResveratrol suppresses apoptosis in intact human cardiac tissue - in vitro model simulating extracorporeal circulation201152399409PMID: 21577194Search in Google Scholar
Zhou R, Yi L, Ye X, Zeng X, Liu K, Qin Y, Zhang Q, Mi M. Resveratrol ameliorates lipid droplet accumulation in liver through a SIRT1/ ATF6-dependent mechanism. Cell Physiol Biochem 2018;51:2397–420. doi: 10.1159/000495898ZhouRYiLYeXZengXLiuKQinYZhangQMiMResveratrol ameliorates lipid droplet accumulation in liver through a SIRT1/ ATF6-dependent mechanism201851239742010.1159/000495898Open DOISearch in Google Scholar
Lin KH, Hsiao G, Shih CM, Chou DS, Sheu JR. Mechanisms of resveratrol-induced platelet apoptosis. Cardiovasc Res 2009;83:575–85. doi: 10.1093/cvr/cvp139LinKHHsiaoGShihCMChouDSSheuJRMechanisms of resveratrol-induced platelet apoptosis2009835758510.1093/cvr/cvp139Open DOISearch in Google Scholar
Rivera L, Morón R, Zarzuelo A, Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 2009;77:1053–63. doi: 10.1016/j.bcp.2008.11.027RiveraLMorónRZarzueloAGalisteoMLong-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats20097710536310.1016/j.bcp.2008.11.027Open DOISearch in Google Scholar
Hausenblas HA, Schoulda JA, Smoliga JM. Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus - systematic review and meta-analysis. Mol Nutr Food Res 2015;59:147–59. doi: 10.1002/mnfr.201400173HausenblasHASchouldaJASmoligaJMResveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus - systematic review and meta-analysis2015591475910.1002/mnfr.201400173Open DOISearch in Google Scholar
Fogacci F, Tocci G, Presta V, Fratter A, Borghi C, Cicero AFG. Effect of resveratrol on blood pressure: a systematic review and meta-analysis of randomized, controlled, clinical trials. Crit Rev Food Sci Nutr 2019;59:1605–18. doi: 10.1080/10408398.2017.1422480FogacciFTocciGPrestaVFratterABorghiCCiceroAFGEffect of resveratrol on blood pressure: a systematic review and meta-analysis of randomized, controlled, clinical trials20195916051810.1080/10408398.2017.1422480Open DOISearch in Google Scholar
Haghighatdoost F, Hariri M. Effect of resveratrol on lipid profile: an updated systematic review and meta-analysis on randomized clinical trials. Pharmacol Res 2018;129:141–50. doi: 10.1016/j.phrs.2017.12.033HaghighatdoostFHaririMEffect of resveratrol on lipid profile: an updated systematic review and meta-analysis on randomized clinical trials20181291415010.1016/j.phrs.2017.12.033Open DOISearch in Google Scholar
Hong S-P, Choi D-H, Choi J-S. Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats. Cardiovasc Ther 2008;26:269–75. doi: 10.1111/j.1755-5922.2008.00060.xHongS-PChoiD-HChoiJ-SEffects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats2008262697510.1111/j.1755-5922.2008.00060.xOpen DOISearch in Google Scholar
Tomé-Carneiro J, Gonzálvez M, Larrosa M, Yáñez-Gascón MJ, García-Almagro FJ, Ruiz-Ros JA, García-Conesa MT, Tomás-Barberán FA, Espín JC. One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease. Am J Cardiol 2012;110:356–63. doi: 10.1016/j.amjcard.2012.03.030Tomé-CarneiroJGonzálvezMLarrosaMYáñez-GascónMJGarcía-AlmagroFJRuiz-RosJAGarcía-ConesaMTTomás-BarberánFAEspínJCOne-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease20121103566310.1016/j.amjcard.2012.03.030Open DOISearch in Google Scholar
Öztürk Y, Günaydın C, Yalçın F, Nazıroğlu M, Braidy N. Resveratrol enhances apoptotic and oxidant effects of paclitaxel through TRPM2 channel activation in DBTRG glioblastoma cells. Oxid Med Cell Longev 2019;2019:4619865. doi: 10.1155/2019/4619865ÖztürkYGünaydınCYalçınFNazıroğluMBraidyNResveratrol enhances apoptotic and oxidant effects of paclitaxel through TRPM2 channel activation in DBTRG glioblastoma cells20192019461986510.1155/2019/4619865Open DOISearch in Google Scholar
Zhu Y, Feng B, He S, Su Z, Zheng G. Resveratrol combined with total flavones of hawthorn alleviate the endothelial cells injury after coronary bypass graft surgery. Phytomedicine 2018;40:20–6. doi: 10.1016/j.phymed.2017.12.037ZhuYFengBHeSSuZZhengGResveratrol combined with total flavones of hawthorn alleviate the endothelial cells injury after coronary bypass graft surgery20184020610.1016/j.phymed.2017.12.037Open DOISearch in Google Scholar
Penumathsa SV, Koneru S, Samuel SM, Maulik G, Bagchi D, Yet SF, Menon VP, Maulik N. Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor. Free Radic Biol Med 2008;45:1027–34. doi: 10.1016/j.freeradbiomed.2008.07.012PenumathsaSVKoneruSSamuelSMMaulikGBagchiDYetSFMenonVPMaulikNStrategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor20084510273410.1016/j.freeradbiomed.2008.07.012Open DOISearch in Google Scholar
Fujitaka K, Otani H, Jo F, Jo H, Nomura E, Iwasaki M, Nishikawa M, Iwasaka T, Das D. Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment. Nutr Res 2011;31:842–7. doi: 10.1016/j. nutres.2011.09.028FujitakaKOtaniHJoFJoHNomuraEIwasakiMNishikawaMIwasakaTDasDModified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment201131842710.1016/j. nutres.2011.09.028Open DOISearch in Google Scholar
Ekshyyan VP, Hebert VY, Khandelwal A, Dugas TR. Resveratrol inhibits rat aortic vascular smooth muscle cell proliferation via estrogen receptor dependent nitric oxide production. J Cardiovasc Pharmacol 2007;50:83–93. doi: 10.1097/FJC.0b013e318059ae8EkshyyanVPHebertVYKhandelwalADugasTRResveratrol inhibits rat aortic vascular smooth muscle cell proliferation via estrogen receptor dependent nitric oxide production200750839310.1097/FJC.0b013e318059ae8Open DOISearch in Google Scholar